Benadryl recall
This article was originally published in The Tan Sheet
Executive Summary
Pfizer initiates voluntary nationwide recall of Benadryl Allergy & Sinus Fastmelt tablets and Benadryl Children's Allergy/Cold Fastmelt tablets June 1. Products incorrectly state the amount of phenylalanine, contained in aspartame, as 1.2 mg per tablet, Pfizer says; correct amount should read 4.6 mg/tablet. Pfizer stresses the labeling error only affects people with phenylketonuria (PKU), a rare inherited metabolic condition; no adverse events have been reported. Consumers who have purchased a Fastmelt product and do not wish to use it can exchange or return the product for a full refund. Revised labeling should be available in several weeks, firm notes